Predicted Trait | |
Reported Trait | HbA1c |
Mapped Trait(s) | HbA1c measurement (EFO_0004541) |
Additional Trait Information | Score composed of erythrocytic variants associated with HbA1c, used to predict diabetes incidence |
Score Construction | |
PGS Name | GS-E-EUR |
Development Method | |
Name | GWAS |
Parameters | Study-wide multi-ancestry GWAS significant SNPs |
Variants | |
Original Genome Build | NCBI36 |
Number of Variants | 21 |
Effect Weight Type | beta |
PGS Source | |
PGS Catalog Publication (PGP) ID | PGP000064 |
Citation (link to publication) | Wheeler E et al. PLoS Med (2017) |
Ancestry Distribution | |
Source of Variant Associations (GWAS) | European: 100% 88,355 individuals (100%) |
PGS Evaluation | European: 100% 1 Sample Sets |
Study Identifiers | Sample Numbers | Sample Ancestry | Cohort(s) |
---|---|---|---|
GWAS Catalog: GCST007954 Europe PMC: 28898252 |
88,355 individuals | European | NR |
PGS Performance Metric ID (PPM) |
PGS Sample Set ID (PSS) |
Performance Source | Trait |
PGS Effect Sizes (per SD change) |
Classification Metrics | Other Metrics | Covariates Included in the Model |
PGS Performance: Other Relevant Information |
---|---|---|---|---|---|---|---|---|
PPM000407 | PSS000236| European Ancestry| 37,357 individuals |
PGP000064 | Wheeler E et al. PLoS Med (2017) |
Reported Trait: Incident type 2 diabetes | OR: 1.0 [0.99, 1.01] | — | — | age, sex | — |
PGS Sample Set ID (PSS) |
Phenotype Definitions and Methods | Participant Follow-up Time | Sample Numbers | Age of Study Participants | Sample Ancestry | Additional Ancestry Description | Cohort(s) | Additional Sample/Cohort Information |
---|---|---|---|---|---|---|---|---|
PSS000236 | Incident type 2 diabtes defined as fasting glucose >= 7 mmol/L, 2 hour glucose >= 11.1 mmol/L, antidiabetic medication use, or a physician diagnosis of type 2 diabetes | Range = [10.0, 15.0] years | [ ,
43.47 % Male samples |
Mean = 54.63 years Sd = 8.27 years |
European | — | ARIC, FHS, InterAct, MESA | Partial overlap with discovery GWAS |